Intra-Cellular Therapies

Manufacturing · New Jersey, United States · 501-1,000 Employees

View Company Info for Free

Overview

Headquarters

135 Route 202/206 Ste 6, Bedminster, New...

Phone Number

(888) 252-4824

Revenue

$680.9 Million

Industry

Manufacturing Pharmaceuticals

About Intra-Cellular Therapies

Johnson & Johnson Innovative Medicine focuses on developing advanced medicines and therapies to address serious health issues and improve patient outcomes. The company utilizes data science and AI to accelerate the discovery and delivery of new treatments, particularly in areas such as oncology, immunology, and neuroscience. Their commitment to precision medicine aims to provide tailored treatments for complex diseases, enhancing the standard of care for patients globally. Johnson & Johnson Innovative Medicine collaborates with healthcare professionals and partners to expand treatment options and reach more patients effectively.Explore more
Intra-Cellular Therapies's Social MediaSIC Code 28,283NAICS Code 32,325Show more

Intra-Cellular Therapies Org Chart

PhoneEmail
SD
United States flag for contact location.

Chief Medical Officer & Executive Vice Presid...

PhoneEmail
DU
United States flag for contact location.

Senior Vice President and Chief Information O...

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
JE
United States flag for contact location.

Vice President, Medical Affairs

PhoneEmail
AP
United States flag for contact location.

Vice President, Head of Clinical Pharmacology

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Intra-Cellular Therapies

Compare insights from companies similar to Intra-Cellular Therapies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Intra-Cellular Therapies

$680.9M
501-1,000
Private
$1.1B
2002
SD
Suresh DurgamChief Medical Officer & Executive Vice President
$3.4B
1K - 5K
Public
$1.5B
1992
$1.1B
501-1,000
Public
$443M
1993
Mark Schneyer, Chief Financial Officer at Acadia
Mark SchneyerChief Financial Officer
$1B
501-1,000
Public
$2.5B
1998
NM
Nilam MistryChief Information Officer & Senior VP
$830.4M
501-1,000
Public
$80M
2005
JK
Jack KhattarPresident & CEO
$215.7M
501-1,000
Public
$57.5M
2003
Mihael Polymeropoulos, President, Chief Executive Officer & Chairman at Vanda Pharmaceuticals
Mihael PolymeropoulosPresident, CEO & Chairman
$65.4M
201-500
Public
$451.3M
2012
PB
Paul BolnoPresident & CEO
Illustration of an envelope

Intra-Cellular Therapies Tech Stack

A closer look at the technologies used by Intra-Cellular Therapies

Top Manufacturing Companies

Frequently Asked Questions Regarding Intra-Cellular Therapies

What is Intra-Cellular Therapies's official website?
Intra-Cellular Therapies's official website is www.intracellulartherapies.com
What is Intra-Cellular Therapies's Revenue?
Intra-Cellular Therapies's revenue is $680.9 Million
What is Intra-Cellular Therapies's SIC code?
Intra-Cellular Therapies's SIC: 28,283
What is Intra-Cellular Therapies's NAICS code?
Intra-Cellular Therapies's NAICS: 32,325
How many employees does Intra-Cellular Therapies have?
Intra-Cellular Therapies has 501-1,000 employees
What industry does Intra-Cellular Therapies belong to?
Intra-Cellular Therapies is in the industry of: Manufacturing, Pharmaceuticals
What is Intra-Cellular Therapies competition?
Intra-Cellular Therapies top competitors include: Neurocrine Biosciences, PTC Therapeutics, Vanda Pharmaceuticals, Acadia
What companies has Intra-Cellular Therapies acquired?
Intra-Cellular Therapies has acquired the companies: Proteologix, Vogue International, TransForm Pharmaceuticals, ColBar LifeScience
What technology does Intra-Cellular Therapies use?
Some of the popular technologies that Intra-Cellular Therapies uses are: WordPress.org, Joomla, PHP, Cloudflare Website Optimization
What does Intra-Cellular Therapies do?

Johnson & Johnson Innovative Medicine focuses on developing advanced medicines and therapies to address serious health issues and improve patient outcomes. The company utilizes data science and AI to accelerate the discovery and delivery of new treatments, particularly in areas such as oncology, immunology, and neuroscience. Their commitment to pre... cision medicine aims to provide tailored treatments for complex diseases, enhancing the standard of care for patients globally. Johnson & Johnson Innovative Medicine collaborates with healthcare professionals and partners to expand treatment options and reach more patients effectively.Read More

What are Intra-Cellular Therapies social media links?
Intra-Cellular Therapies Linkedin page Intra-Cellular Therapies Facebook page
Who invested in Intra-Cellular Therapies?
Intra-Cellular Therapies has 9 investors including Deerfield, Broadfin Capital, Audubon Biomedical Science and Alexandria Equities LLC.
Is Intra-Cellular Therapies a public company?
Intra-Cellular Therapies is private company therefore does not currently have an official ticker symbol
See more information about Intra-Cellular Therapies

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.